Kumar Balasubramanian

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial.

Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial.

Journal: JAMA internal medicine

Published: August 30, 2026

Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage: A Placebo-Controlled Trial.

Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage: A Placebo-Controlled Trial.

Journal: Stroke

Published: August 06, 2026

Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral.

Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral.

Journal: JACC. CardioOncology

Published: July 17, 2026

Re: Tikkinen KAO, Marcucci M, Halme ALE, et al. Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-Controlled POISE-3 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.019.

Re: Tikkinen KAO, Marcucci M, Halme ALE, et al. Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-Controlled POISE-3 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.019.

Journal: European urology

Published: July 13, 2026

Erratum: Author Corrections to "Smoking, Colchicine, and Postoperative Outcomes in Thoracic Surgery: Post Hoc Analysis of the COP-AF Randomized Controlled Trial: [CJC Open Volume 7, Issue 7, July 2025, pages 860-870]".

Erratum: Author Corrections to "Smoking, Colchicine, and Postoperative Outcomes in Thoracic Surgery: Post Hoc Analysis of the COP-AF Randomized Controlled Trial: [CJC Open Volume 7, Issue 7, July 2025, pages 860-870]".

Journal: CJC open

Published: April 20, 2026

Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-Controlled POISE-3 Trial.

Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-Controlled POISE-3 Trial.

Journal: European urology

Published: February 16, 2026

Rationale, design, and experiences from the vanguard phase of the bariatric surgery for the reduction of cardiovascular events (BRAVE) trial.

Rationale, design, and experiences from the vanguard phase of the bariatric surgery for the reduction of cardiovascular events (BRAVE) trial.

Journal: American heart journal

Published: December 30, 2025

Rationale, Design, and Experiences from the Vanguard Phase of the Bariatric Surgery for the Reduction of Cardiovascular Events (BRAVE) Trial.

Rationale, Design, and Experiences from the Vanguard Phase of the Bariatric Surgery for the Reduction of Cardiovascular Events (BRAVE) Trial.

Journal: American heart journal

Published: December 30, 2025

Pain as a Driver of Myocardial Injury in Hip Fracture Patients: A Hip Fracture Accelerated Surgical Treatment and Care Track (HIP ATTACK) Trial Secondary Analysis.

Pain as a Driver of Myocardial Injury in Hip Fracture Patients: A Hip Fracture Accelerated Surgical Treatment and Care Track (HIP ATTACK) Trial Secondary Analysis.

Journal: Anesthesiology

Published: October 28, 2025

Effects of a Hypotension-Avoidance Versus a Hypertension-Avoidance Strategy on Neurocognitive Outcomes After Noncardiac Surgery.

Effects of a Hypotension-Avoidance Versus a Hypertension-Avoidance Strategy on Neurocognitive Outcomes After Noncardiac Surgery.

Journal: Annals of internal medicine

Published: June 02, 2025

Diet and Clinical Outcomes in a Heart Failure Population.

Diet and Clinical Outcomes in a Heart Failure Population.

Journal: JACC. Heart failure

Published: May 13, 2025

Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial.

Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial.

Journal: Lancet (London, England)

Published: May 06, 2025

Showing 1-12 of 56

Last Updated: 09/26/2026